» Articles » PMID: 1833354

Alcohol and Tobacco Consumption As Risk Factors for Alzheimer's Disease: a Collaborative Re-analysis of Case-control Studies. EURODEM Risk Factors Research Group

Overview
Journal Int J Epidemiol
Specialty Public Health
Date 1991 Jan 1
PMID 1833354
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

A meta-analysis, involving the secondary analysis of original data from 11 case-control studies of Alzheimer's disease, is presented for alcohol consumption and cigarette smoking. Five studies included in the meta-analysis of alcohol consumption. Alcohol consumption was computed in terms of average weekly intake, measured in ounces of 'pure alcohol'. This variable was categorized into tertiles to represent low, medium and high intake. Analyses showed no excess estimated risk of Alzheimer's disease for any level of alcohol intake. Smoking was analysed in three different manners: (1) lifetime prevalence of smoking (ever/never)--this included eight studies; (2) amount smoked (less than or equal to one pack per day versus more than one pack per day)--this included seven studies; and (3) pack-years--including four studies. A statistically significant inverse association between smoking and Alzheimer's disease was observed at all levels of analysis, with a trend towards decreasing risk with increasing consumption (p(trend) = 0.0003). A propensity towards a stronger inverse relation was observed among patients with a positive family history of dementia, but the difference between this group and the group with no such history was not statistically significant. Although the observed disturbance in nicotinic receptor function in Alzheimer's disease may provide an explanation for these findings, possible biases related to the selection or survival of study subjects cannot be fully ruled out at this time. Prospective, community-based studies of incident cases of Alzheimer's disease are needed to document in detail the smoking history, age of onset of disease and survival of patients and cognitively intact people by smoking status.

Citing Articles

Tobacco cigarette smoking induces cerebrovascular dysfunction followed by oxidative neuronal injury with the onset of cognitive impairment.

Ewees M, El-Mahdy M, Hannawi Y, Zweier J J Cereb Blood Flow Metab. 2024; 45(1):48-65.

PMID: 39136181 PMC: 11572251. DOI: 10.1177/0271678X241270415.


Systematic replication of smoking disease associations using survey responses and EHR data in the All of Us Research Program.

Schlueter D, Sulieman L, Mo H, Keaton J, Ferrara T, Williams A J Am Med Inform Assoc. 2023; 31(1):139-153.

PMID: 37885303 PMC: 10746325. DOI: 10.1093/jamia/ocad205.


Thwarting Alzheimer's Disease through Healthy Lifestyle Habits: Hope for the Future.

Govindugari V, Golla S, Reddy S, Chunduri A, Nunna L, Madasu J Neurol Int. 2023; 15(1):162-187.

PMID: 36810468 PMC: 9944470. DOI: 10.3390/neurolint15010013.


Clarifying the neurobehavioral sequelae of moderate drinking lifestyles and acute alcohol effects with aging.

Nixon S, Lewis B Int Rev Neurobiol. 2019; 148:39-78.

PMID: 31733667 PMC: 7391998. DOI: 10.1016/bs.irn.2019.10.016.


Gene-environment interactions in Alzheimer's disease: A potential path to precision medicine.

Eid A, Mhatre I, Richardson J Pharmacol Ther. 2019; 199:173-187.

PMID: 30877021 PMC: 6827882. DOI: 10.1016/j.pharmthera.2019.03.005.